SAB BIOTHERAPEUTICS, INC. (SABS) Net income 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$13.3MFY2025 · since FY2020: $20.1M → $13.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.3M | +138.9% |
| FY2024 | -$34.1M | +19.2% |
| FY2023 | -$42.2M | -125.1% |
| FY2022 | -$18.7M | -9.3% |
| FY2021 | -$17.1M | -185.2% |
| FY2020 | $20.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice